Whitehawk Therapeutics Inc
NASDAQ:WHWKBiotechnology
Healthcare
$3.12 +1.42%
+$0.06 today
- Market cap
- $184.11M
- Beta
- 0.77
- P/E (TTM)
- -2.6
- EPS (TTM)
- -$1.67
52W Low $1.57High $5.50
Volume 0.40M
Average 0.31M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$97.43M
FY 2025 · Annual
Investing Cash Flow
$11.89M
FY 2025 · Annual
-52.8% YoYFinancing Cash Flow
$94.38M
FY 2025 · Annual
+72496.9% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (110.09M) | (60.51M) | (65.77M) | (63.69M) | (20.6M) |
| Depreciation & Amortization | 105K | 159K | 169K | 193K | 79K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 2.11M | 9.64M | 11.95M | 10.84M | 9.87M |
| Change in Working Capital | 3.96M | (5.04M) | (3.27M) | 3.72M | 1.93M |
| Accounts Receivables | 14.15M | (1.86M) | (3.63M) | (415K) | (1M) |
| Inventory | 0 | (1.86M) | (3.27M) | 1.12M | 170K |
| Accounts Payables | 0 | 0 | 0 | 0 | 3.92M |
| Other Working Capital | (10.19M) | (1.32M) | 3.62M | 3.02M | (1.16M) |
| Other Non-Cash Items | 81.5M | 6.11M | (2.75M) | (10.61M) | (78.77M) |
| Operating Cash Flow | (22.42M) | (49.64M) | (59.66M) | (59.55M) | (97.43M) |
| Capital Expenditures | (46K) | (444K) | (3.97M) | (1.65M) | (552K) |
| Acquisitions (Net) | 25.2M | 0 | 0 | 0 | 101.29M |
| Purchases of Investments | 0 | (145.19M) | (64.44M) | (36.48M) | (148.69M) |
| Sales of Investments | 0 | 12.75M | 151.62M | 63.34M | 59.85M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 25.15M | (132.89M) | 83.21M | 25.2M | 11.89M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 155M | 72.5M | 0 | 130K | 100M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (4.41M) | 0 | 0 | 0 | 0 |
| Other Financing Activities | (8.78M) | 120K | 326K | (16K) | (5.63M) |
| Financing Cash Flow | 141.8M | 72.62M | 326K | 130K | 94.38M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 64K |
| Net Change in Cash | 144.53M | (109.91M) | 23.87M | (34.22M) | 8.9M |
| Free Cash Flow | (22.47M) | (50.08M) | (63.64M) | (61.2M) | (97.99M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$20.6M
+ D&A$79.0K
+ Stock-Based Comp$9.9M
+ Deferred Tax$0
+ Working Capital$1.9M
- Other Non-Cash-$78.8M
= Operating Cash Flow-$97.4M
- Capex-$552.0K
= Free Cash Flow-$98.0M
Analysis
FY2025 free cash flow is -$98.0M. FCF conversion is 475.7% of net income. Operating cash flow was -$97.4M, with capex of -$552.0K. The largest bridge item is Other Non-Cash at -$78.8M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| DEFA14A | DEFA14A filing | Apr 28, 2026 | |
| ARS | ARS filing | Apr 28, 2026 |
Does WHWK generate free cash flow?
Whitehawk Therapeutics Inc (WHWK) generated -$97.98M of free cash flow in fiscal 2025.
How much operating cash flow does WHWK produce?
Operating cash flow was -$97.43M, before capital expenditures of $552,000.00.
Continue the stock analysis
Jump to another research area for this company.